Let's talk medical research

This blog examines 5 reasons why it can be difficult to recruit participants for clinical trials and offers solutions specific to each.

Patient-centric clinical trial listings can better engage patients and increase enrollment rates. Learn more about how to improve listings from this blog.

From our 2023 patient survey, we learn about what motivates patients to participate in clinical trials and how outreach can speak to these values.

Primary sclerosing cholangitis is a condition that impacts the liver, but many patients don’t initially exhibit symptoms. Learn more about PSC today.

Persistent corneal epithelial defects are more than just an eye injury. Learn more about this unique condition and how clinical trials can help.

Different types of clinical trials, such as observational vs. interventional, may require varied advertising approaches, our research suggests.

Hypertension is always a serious condition, but resistant hypertension can be difficult to treat. Learn more about what this means in the blog.

Chronic kidney disease is a common condition, but it’s also a serious one. Learn more about CKD and treatment options in our latest blog.

These facts are inspired by Alzheimer’s and Brain Awareness Month, a holiday aimed at spreading awareness about Alzheimer’s disease and other dementias.

In order to connect patients with medical research, but to do that, it's important to understand what motivates patients to participate in clinical trials.

A breast cancer diagnosis can be devastating, but early detection can improve a patient’s prognosis tremendously.

Because IgAN has no known cure, diagnosed individuals must focus on symptom management to reduce the impact of the disease.

Anticipating the challenges that come with executing a trial is critical to its success. Here’s how to address key pain points when it comes to managing clinical trials.

There are several reasons to consider participating in research studies, from accessing the latest treatment options to helping move research forward.

We recently sat down with one of our partners, Rare Patient Voice, to discuss clinical research, patient centricity, and more.